Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0812 per EA under NDC 59746033910. Its NADAC has been published 266 times since Jan 27, 2021.

The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB

losartan potassium and hydrochlorothiazide
$0.0812per EA
High Outlier

Strength

25; 100 mg/1; mg/1

NDC

59746033910

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201845

On Market Since

10/30/2012

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 266 times since Jan 27, 2021, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0812 per EA
All-time high$0.2811 (May 11, 2022)
All-time low$0.0780 (Nov 20, 2024)
52-week high$0.0876
52-week low$0.0812
Median price$0.1309
Average price$0.1367
Largest weekly change+33.4% (Apr 20, 2022)
Weeks tracked266
Tracking sinceJan 27, 2021

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-1.4%

1Y

-4.4%

3Y

-35.8%

5Y

-56.0%

All

-55.9%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0812 per EA (NDC 59746033910), effective Feb 25, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has declined 55.9%. It has been tracked across 266 weekly CMS publications since Jan 27, 2021.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

Since Jan 27, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.0780 (Nov 20, 2024) to a high of $0.2811 (May 11, 2022), with a median of $0.1309 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB, is $0.0798 per EA — about 2% below LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 59746033910) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.